URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Deepak Sahasrabudhe

Concepts (217)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antigens, Neoplasm
5
1987
106
0.870
Why?
Polymorphism, Single Nucleotide
2
2010
90
0.740
Why?
Tissue Kallikreins
1
2010
11
0.720
Why?
Prostatic Neoplasms
3
2008
555
0.630
Why?
T-Lymphocytes, Cytotoxic
2
2001
128
0.540
Why?
HLA Antigens
1
2006
99
0.540
Why?
Receptors, Antigen, T-Cell
1
2006
66
0.540
Why?
Leukemia, Myeloid
1
2006
119
0.520
Why?
Colonic Neoplasms
2
1999
124
0.500
Why?
Antigens, Differentiation, Myelomonocytic
1
2003
23
0.440
Why?
Immune Tolerance
4
1986
144
0.440
Why?
Receptor, Epidermal Growth Factor
1
2003
93
0.410
Why?
Vascular Endothelial Growth Factor A
1
2003
203
0.390
Why?
Antigens, CD
1
2003
244
0.390
Why?
Organ Transplantation
1
2000
11
0.380
Why?
Antigens, CD20
1
2000
22
0.370
Why?
Lymphoproliferative Disorders
1
2000
30
0.370
Why?
T-Lymphocytes, Regulatory
3
1987
49
0.350
Why?
Sarcoma
2
2008
63
0.340
Why?
T-Lymphocytes
4
1986
550
0.330
Why?
Carcinoma, Renal Cell
2
1986
55
0.310
Why?
Kidney Neoplasms
2
1986
103
0.300
Why?
Neoplasms, Second Primary
2
2008
125
0.270
Why?
Middle Aged
12
1981
9837
0.270
Why?
Prognosis
4
1981
1083
0.270
Why?
Immunotherapy, Active
2
1990
4
0.270
Why?
Aged
12
1981
7269
0.270
Why?
Interferon-beta
1
1994
63
0.240
Why?
Interferon-alpha
1
1994
83
0.240
Why?
Neoadjuvant Therapy
2
2008
32
0.230
Why?
Neoplasms, Experimental
1
1994
145
0.230
Why?
Hypersensitivity, Delayed
2
1986
49
0.230
Why?
Genetic Markers
2
2010
134
0.220
Why?
Humans
22
1981
36274
0.220
Why?
Lung Neoplasms
3
1992
439
0.220
Why?
Raynaud Disease
1
1992
6
0.210
Why?
Paraneoplastic Syndromes
1
1992
12
0.210
Why?
Male
13
1981
19675
0.210
Why?
Spermatozoa
1
2012
33
0.210
Why?
Genotype
2
2010
490
0.200
Why?
Urinary Bladder Neoplasms
2
2005
173
0.200
Why?
Deferoxamine
1
1991
16
0.200
Why?
Deoxycytidine
1
2011
28
0.200
Why?
Androgen Antagonists
1
2012
65
0.200
Why?
Cisplatin
1
2011
95
0.190
Why?
Aged, 80 and over
4
2005
2529
0.190
Why?
Retrospective Studies
5
1990
2267
0.180
Why?
Radiosurgery
1
2011
74
0.180
Why?
Adult
8
1986
11351
0.170
Why?
Disease-Free Survival
1
2010
198
0.170
Why?
Alleles
1
2010
205
0.170
Why?
Breast Neoplasms
2
2004
673
0.160
Why?
Soft Tissue Neoplasms
1
2008
46
0.160
Why?
Amino Acid Sequence
3
2001
1195
0.150
Why?
Graft vs Host Disease
1
2008
90
0.150
Why?
Recurrence
1
2010
691
0.150
Why?
Interferon Type I
1
1987
37
0.150
Why?
Cimetidine
1
1987
8
0.150
Why?
Female
12
1986
19838
0.150
Why?
Mice, Inbred BALB C
4
1987
632
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2011
429
0.150
Why?
Skin Diseases
1
2008
120
0.140
Why?
Bone Marrow Transplantation
1
2008
197
0.140
Why?
Leukemia, Myeloid, Acute
1
2008
177
0.140
Why?
Urologic Neoplasms
1
2005
10
0.130
Why?
Tumor Cells, Cultured
3
1993
881
0.130
Why?
Quinolones
1
2005
27
0.130
Why?
Acute Disease
2
1983
586
0.130
Why?
Neoplasm Proteins
1
2006
173
0.130
Why?
Dinitrofluorobenzene
3
1987
7
0.130
Why?
Carcinoma, Transitional Cell
1
2005
53
0.130
Why?
Tumor Markers, Biological
1
2006
229
0.120
Why?
Molecular Sequence Data
2
2006
1988
0.120
Why?
Mice
6
1987
6111
0.120
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2004
47
0.120
Why?
CD8-Positive T-Lymphocytes
1
2006
224
0.120
Why?
Cytotoxicity, Immunologic
2
1993
115
0.120
Why?
Acetates
1
2004
64
0.120
Why?
Hot Flashes
1
2004
28
0.120
Why?
Cell Line, Tumor
1
2006
575
0.110
Why?
Tamoxifen
1
2004
81
0.110
Why?
Cyclohexanecarboxylic Acids
1
2004
48
0.110
Why?
Amines
1
2004
65
0.110
Why?
Neoplasm Metastasis
2
1986
228
0.110
Why?
Angiogenesis Inducing Agents
1
2003
13
0.110
Why?
gamma-Aminobutyric Acid
1
2004
98
0.110
Why?
Enzyme Inhibitors
1
2005
422
0.110
Why?
Dendritic Cells
1
2004
121
0.110
Why?
Adenoviridae
1
2003
128
0.110
Why?
Colorectal Neoplasms
1
2004
137
0.110
Why?
Macrophages
1
2004
346
0.100
Why?
Genes, Lethal
1
2001
12
0.100
Why?
Melanoma
1
2003
134
0.100
Why?
Immunoglobulins
1
1981
70
0.100
Why?
Interferon-gamma
1
2003
348
0.100
Why?
Multiple Myeloma
1
1981
76
0.090
Why?
Multivariate Analysis
1
2003
541
0.090
Why?
Animals
7
1987
16093
0.090
Why?
Cell Division
2
1991
762
0.090
Why?
Herpesvirus 4, Human
1
2000
62
0.090
Why?
Intestine, Small
1
2000
111
0.090
Why?
Antibodies, Monoclonal, Murine-Derived
1
2000
114
0.090
Why?
Chemotherapy, Adjuvant
2
2008
88
0.090
Why?
Lymphoma, Large B-Cell, Diffuse
1
2000
78
0.090
Why?
Antineoplastic Agents
1
2005
619
0.090
Why?
Time Factors
3
1983
3182
0.080
Why?
Cancer Vaccines
1
1999
33
0.080
Why?
Recombinant Proteins
1
2001
723
0.080
Why?
Treatment Outcome
4
1999
2615
0.080
Why?
Rectal Neoplasms
1
1999
82
0.080
Why?
Interleukin-1
1
1999
218
0.080
Why?
Liver Transplantation
1
2000
237
0.080
Why?
Skin Tests
3
1987
29
0.080
Why?
Medical Oncology
1
1997
48
0.070
Why?
Fellowships and Scholarships
1
1997
52
0.070
Why?
Adenocarcinoma
2
1992
439
0.070
Why?
Cyclophosphamide
2
1986
174
0.070
Why?
Geriatrics
1
1997
78
0.070
Why?
Antibodies, Monoclonal
1
2000
711
0.070
Why?
Postoperative Complications
1
2000
733
0.070
Why?
Plasmacytoma
1
1994
10
0.060
Why?
Mice, Inbred DBA
1
1994
92
0.060
Why?
Infant
1
2000
2278
0.060
Why?
HLA-A2 Antigen
1
1993
9
0.060
Why?
Histocompatibility Antigens Class I
1
1994
95
0.060
Why?
Gene Products, gag
1
1993
17
0.060
Why?
Administration, Oral
2
2004
308
0.060
Why?
DNA, Complementary
2
2001
264
0.060
Why?
RNA, Messenger
1
2000
1863
0.060
Why?
Histocompatibility Antigens Class II
1
1994
189
0.060
Why?
Amputation
1
1992
24
0.050
Why?
Genetic Association Studies
1
2012
19
0.050
Why?
tRNA Methyltransferases
1
2012
19
0.050
Why?
Immunohistochemistry
2
2004
1064
0.050
Why?
Treatment Failure
1
2012
128
0.050
Why?
Fingers
1
1992
70
0.050
Why?
Child
1
2000
4155
0.050
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.050
Why?
Ferric Compounds
1
1991
25
0.050
Why?
Sarcoma, Synovial
1
2011
7
0.050
Why?
Immunosuppression
1
1991
64
0.050
Why?
Leiomyosarcoma
1
2011
18
0.050
Why?
Liver Neoplasms
1
1992
151
0.050
Why?
Chlorides
1
1991
123
0.050
Why?
Radiotherapy Dosage
1
2011
203
0.050
Why?
Genetic Vectors
2
2001
339
0.040
Why?
Prospective Studies
2
2004
1689
0.040
Why?
Predictive Value of Tests
1
2012
606
0.040
Why?
Survivors
1
2011
118
0.040
Why?
Radiation Injuries
1
2011
131
0.040
Why?
Abdominal Neoplasms
1
2008
17
0.040
Why?
Biopsy, Fine-Needle
1
2008
21
0.040
Why?
Carcinoid Tumor
1
2008
26
0.040
Why?
Adenoma
1
2008
54
0.040
Why?
Pituitary Neoplasms
1
2008
66
0.040
Why?
Radiotherapy, Adjuvant
1
2008
73
0.040
Why?
Cohort Studies
1
2011
969
0.040
Why?
Antigens
1
1987
99
0.040
Why?
Diphenhydramine
1
1987
9
0.040
Why?
Transplantation, Homologous
1
2008
276
0.040
Why?
Hybrid Cells
1
1987
26
0.040
Why?
Immunization, Passive
1
1987
66
0.040
Why?
Cells, Cultured
1
1993
2479
0.040
Why?
Skin
1
1990
377
0.040
Why?
Antigens, Surface
1
1987
98
0.040
Why?
Immunotherapy
1
1986
86
0.030
Why?
Spleen
1
1987
341
0.030
Why?
Young Adult
1
2011
1059
0.030
Why?
Chronic Disease
1
2008
522
0.030
Why?
Receptor, erbB-2
1
2006
68
0.030
Why?
Urothelium
1
2005
20
0.030
Why?
Exanthema
1
2005
12
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2006
138
0.030
Why?
Diarrhea
1
2005
66
0.030
Why?
Remission Induction
1
2005
161
0.030
Why?
Neutropenia
1
2005
67
0.030
Why?
Eosinophils
1
2004
49
0.030
Why?
Microsatellite Repeats
1
2004
45
0.030
Why?
Arabinofuranosyluracil
1
1983
2
0.030
Why?
Mast Cells
1
2004
47
0.030
Why?
Tomography, X-Ray Computed
1
2008
759
0.030
Why?
Cytarabine
1
1983
89
0.030
Why?
Uridine
1
1983
36
0.030
Why?
Risk Assessment
1
2008
884
0.030
Why?
Injections, Intralesional
1
2003
13
0.030
Why?
Killer Cells, Natural
1
2004
121
0.030
Why?
beta 2-Microglobulin
1
2003
19
0.030
Why?
Leukemia
1
1983
158
0.030
Why?
Pilot Projects
1
2004
442
0.030
Why?
Survival Analysis
1
2004
606
0.030
Why?
Adolescent
1
2011
4766
0.020
Why?
Risk Factors
1
2008
2345
0.020
Why?
Ribosomal Proteins
1
2001
42
0.020
Why?
Vaccinia virus
1
2001
53
0.020
Why?
Interleukin-6
1
2003
339
0.020
Why?
Neoplasms
1
1987
739
0.020
Why?
Follow-Up Studies
1
2005
1855
0.020
Why?
Severity of Illness Index
1
2004
922
0.020
Why?
Hepatitis B Antibodies
1
1999
11
0.020
Why?
Lipid A
1
1999
9
0.020
Why?
Mycobacterium
1
1999
7
0.020
Why?
Adjuvants, Immunologic
1
1999
117
0.020
Why?
Base Sequence
1
2001
1683
0.020
Why?
Gene Expression Regulation
1
2001
888
0.020
Why?
Cell Fusion
1
1987
25
0.010
Why?
DNA, Neoplasm
1
1987
128
0.010
Why?
HeLa Cells
1
1987
296
0.010
Why?
Vaccination
1
1987
232
0.010
Why?
Flow Cytometry
1
1987
603
0.010
Why?
Nucleoside Deaminases
1
1983
19
0.010
Why?
Radioimmunoassay
1
1983
115
0.010
Why?
Infusions, Parenteral
1
1983
72
0.010
Why?
Chromatography, High Pressure Liquid
1
1983
208
0.010
Why?
Kinetics
1
1983
1391
0.010
Why?
Dose-Response Relationship, Drug
1
1983
1117
0.010
Why?
Models, Biological
1
1983
1008
0.000
Why?

Visualizations


Sahasrabudhe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department